Ignite Creation Date:
2024-07-17 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06500273
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2024-06-26
Brief Title:
Consolidation of First-Line MRD Remission with Cema-cel in Patients with LBCL
Sponsor:
Allogene Therapeutics
Organization:
Allogene Therapeutics
Organization Data
Organization:
Allogene Therapeutics
Class:
INDUSTRY
Study ID:
ALLO-501A-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Allogene Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Foresight Diagnostics Inc | UNKNOWN |